153 related articles for article (PubMed ID: 20034596)
1. Enhancement of immune responses to influenza vaccine (H3N2) by ginsenoside Re.
Song X; Chen J; Sakwiwatkul K; Li R; Hu S
Int Immunopharmacol; 2010 Mar; 10(3):351-6. PubMed ID: 20034596
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Re as an adjuvant to enhance the immune response to the inactivated rabies virus vaccine in mice.
Su X; Pei Z; Hu S
Int Immunopharmacol; 2014 Jun; 20(2):283-9. PubMed ID: 24680943
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice.
Sun J; Hu S; Song X
Vaccine; 2007 Jan; 25(6):1114-20. PubMed ID: 17069940
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel acts as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice.
Yuan L; Wu L; Chen J; Wu Q; Hu S
Vaccine; 2010 Jun; 28(27):4402-10. PubMed ID: 20434553
[TBL] [Abstract][Full Text] [Related]
5. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
[TBL] [Abstract][Full Text] [Related]
6. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
7. Ginseng stem-leaf saponins (GSLS) and mineral oil act synergistically to enhance the immune responses to vaccination against foot-and-mouth disease in mice.
Song X; Bao S; Wu L; Hu S
Vaccine; 2009 Jan; 27(1):51-5. PubMed ID: 18973783
[TBL] [Abstract][Full Text] [Related]
8. Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.
Baz M; Samant M; Zekki H; Tribout-Jover P; Plante M; Lanteigne AM; Hamelin ME; Mallett C; Papadopoulou B; Boivin G
Clin Vaccine Immunol; 2012 Feb; 19(2):209-18. PubMed ID: 22190392
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicity.
de Vries JJ; Bungener L; Ter Veer W; van Alphen L; van der Ley P; Wilschut J; Huckriede A
Vaccine; 2009 Feb; 27(6):947-55. PubMed ID: 19059296
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice.
Hauge S; Madhun AS; Cox RJ; Brokstad KA; Haaheim LR
Scand J Immunol; 2007 Jan; 65(1):14-21. PubMed ID: 17212762
[TBL] [Abstract][Full Text] [Related]
11. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
12. A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.
Joseph A; Itskovitz-Cooper N; Samira S; Flasterstein O; Eliyahu H; Simberg D; Goldwaser I; Barenholz Y; Kedar E
Vaccine; 2006 May; 24(18):3990-4006. PubMed ID: 16516356
[TBL] [Abstract][Full Text] [Related]
13. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
Khajuria A; Gupta A; Malik F; Singh S; Singh J; Gupta BD; Suri KA; Suden P; Srinivas VK; Ella K; Qazi GN
Vaccine; 2007 Jun; 25(23):4586-94. PubMed ID: 17498851
[TBL] [Abstract][Full Text] [Related]
14. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.
Ann J; Samant M; Rheaume C; Dumas C; Beaulieu E; Morasse A; Mallett C; Hamelin ME; Papadopoulou B; Boivin G
Vaccine; 2014 Sep; 32(43):5730-9. PubMed ID: 25173481
[TBL] [Abstract][Full Text] [Related]
15. Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice.
Hovden AO; Cox RJ; Haaheim LR
Scand J Immunol; 2005 Jul; 62(1):36-44. PubMed ID: 16092921
[TBL] [Abstract][Full Text] [Related]
16. Novel polysaccharide adjuvant from the roots of Actinidia eriantha with dual Th1 and Th2 potentiating activity.
Sun HX; Wang H; Xu HS; Ni Y
Vaccine; 2009 Jun; 27(30):3984-91. PubMed ID: 19389450
[TBL] [Abstract][Full Text] [Related]
17. Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses.
Xie Y; Deng W; Sun H; Li D
Int Immunopharmacol; 2008 Aug; 8(8):1143-50. PubMed ID: 18550019
[TBL] [Abstract][Full Text] [Related]
18. Effect of methotrexate on Th1 and Th2 immune responses in mice.
Yamaki K; Uchida H; Harada Y; Li X; Yanagisawa R; Takano H; Hayashi H; Taneda S; Mori Y; Yoshino S
J Pharm Pharmacol; 2003 Dec; 55(12):1661-6. PubMed ID: 14738593
[TBL] [Abstract][Full Text] [Related]
19. Amplified immune response by ginsenoside-based nanoparticles (ginsomes).
Song X; Zang L; Hu S
Vaccine; 2009 Apr; 27(17):2306-11. PubMed ID: 19428844
[TBL] [Abstract][Full Text] [Related]
20. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
